If caught early, Natalizumab-PML not fatal for MS patients

examiner.com — The newest research is showing that, caught early, PML doesn't have to be as much of a worry as it has been. "We used to think PML was always fatal, but now we are learning that it might not always be," says Kate Weiss, a spokesperson for Biogen, Inc., the makers of natalizumab. Jul 22, 2010 View in Crawl 4